Compounds 47 and 48 (Figure 6), with IC 50 values of 0.83 and 0.43 M, respectively, which possess aryl-substituted piperazines with acetamide linkers, showed the best activity as DPP-4 inhibitors
Anti-liraglutide antibodies were detected in 42 (2.8%) of 1505 SAXENDA-treated adult patients with a post-baseline assessment
Once desired results are achieved, maintenance sessions may be recommended at longer intervals
Lead study author, Hamlet Gasoyan, DS, PhD, MPH, a researcher with Cleveland Clinics Center for Value-Based Care Research, spoke to Medical News Today , emphasizing the importance of these results in a real-world setting: Randomized clinical trials documented that discontinuation of novel obesity medications generally leads patients to regain weight, Gasoyan told us
Five formats total more administration-route variety than any other program reviewed